** Radiopharm Theranostics RAD.AX leaps as much as 50% to A$0.036; set for biggest ever intraday pct gain
** Biopharma secures private placement agreement with Massachusetts-based Lantheus Holdings LNTH.O to raise $5 mln
** Issue price of A$0.060 represents 150% premium to last close
** Co earlier signed co-development deal with the NASDAQ-listed firm to develop biopharmaceuticals in Australia
** Stock hits its highest level since Dec. 10, 2024
** More than 12.9 mln shares traded, 1.2x the 30-day avg
** RAD fell 67.6% in 2024 - third consecutive bear run since 2022
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。